TickerFiles

bioAffinity Technologies, Inc. 10-Q filing

Filed 2025-08-14 · Report date 2025-06-30 · 2025

View Original SEC Filing

Filing metadata

Accession number
0001641172-25-024163
Form type
10-Q
CIK
0001712762
Primary document
https://www.sec.gov/Archives/edgar/data/1712762/000164117225024163/form10-q.htm

Extracted primary information

This filing includes deterministic financial metrics extracted from public filing data for bioAffinity Technologies, Inc..

Reported financial metrics

MetricCurrentPriorChange
Revenue$3.1M--
Operating Income$-5.1M--
Net Income$-6.7M--
Eps Basic-0.2--
Eps Diluted-0.2--
Cash And Equivalents$802,835--
Total Assets$4.8M--
Total Liabilities$6.9M--
Shareholders Equity$-2.1M--
Operating Cash Flow$-4.3M--
Capital Expenditures$64,213--